Tu My To

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Replacement Therapy

Health Insurance

Drug Administration

Top Venues

Advances in therapy

Future oncology (London, England)

JCO precision oncology

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) (2024)
William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) 20 (16) (2024)
William Bruce Wong, Danny Sheinson, Yutong Liu, Tu My To
Costs associated with the use of multigene panel tests in three solid tumor types and the impact on insurance premiums. Future oncology (London, England) (2023)
Tu My To, Jamie T Ta, Anisha M Patel, Stella Arndorfer, Ibrahim M Abbass, Rita Gandhy
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: A claims‑based retrospective cohort study. Journal of medical economics (2023)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
Mitra Corral, Rita de Cassia Castro, Tu My To, Stella Arndorfer, Shu Wang, John Stephens
Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza. Journal of medical economics 25 (1) (2022)